Transcriptomic immaturity inducible by neural hyperexcitation is shared by multiple neuropsychiatric disorders

[1]  T. Miyakawa,et al.  Immature-like molecular expression patterns in the hippocampus of a mouse model of dementia with Lewy body-linked mutant β-synuclein , 2018, Molecular Brain.

[2]  T. Miyakawa,et al.  Immature morphological properties in subcellular-scale structures in the dentate gyrus of Schnurri-2 knockout mice: a model for schizophrenia and intellectual disability , 2017, Molecular Brain.

[3]  I. Petrof,et al.  Epigenetic suppression of hippocampal calbindin-D28k by ΔFosB drives seizure-related cognitive deficits , 2017, Nature Medicine.

[4]  R. Dingledine,et al.  Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models , 2017, Scientific Data.

[5]  K. Vossel,et al.  Epileptic activity in Alzheimer's disease: causes and clinical relevance , 2017, The Lancet Neurology.

[6]  Alice D. Lam,et al.  Silent Hippocampal Seizures and Spikes Identified by Foramen Ovale Electrodes in Alzheimer’s Disease , 2017, Nature Medicine.

[7]  B Devlin,et al.  Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease , 2017, Molecular Psychiatry.

[8]  Tsuyoshi Miyakawa,et al.  Transcriptomic immaturity of the hippocampus and prefrontal cortex in patients with alcoholism , 2017, Scientific Reports.

[9]  Hidenori Suzuki,et al.  Rapid and stable changes in maturation-related phenotypes of the adult hippocampal neurons by electroconvulsive treatment , 2017, Molecular Brain.

[10]  P. Thuras,et al.  GABAA and GABAB receptor dysregulation in superior frontal cortex of subjects with schizophrenia and bipolar disorder , 2017, Synapse.

[11]  Heidi E Kirsch,et al.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease , 2016, Annals of neurology.

[12]  T. Sejnowski,et al.  Beyond excitation/inhibition imbalance in multidimensional models of neural circuit changes in brain disorders , 2016, bioRxiv.

[13]  P. Callaerts,et al.  A network of synaptic genes associated with schizophrenia and bipolar disorder , 2016, Schizophrenia Research.

[14]  Hironori K. Nakamura,et al.  Circadian Gene Circuitry Predicts Hyperactive Behavior in a Mood Disorder Mouse Model. , 2016, Cell reports.

[15]  W. Chung,et al.  Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features , 2016, neurogenetics.

[16]  S. Horvath,et al.  Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap , 2016, Science.

[17]  J. Nurnberger,et al.  Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder , 2015, Nature.

[18]  T. Wieland,et al.  Loss-of-function variants in HIVEP2 are a cause of intellectual disability , 2015, European Journal of Human Genetics.

[19]  T. Insel,et al.  Brain disorders? Precisely , 2015, Science.

[20]  F. Edwards,et al.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.

[21]  M. Owen,et al.  Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity , 2015, Biological Psychiatry.

[22]  P. Matthews,et al.  A common brain network links development, aging, and vulnerability to disease , 2014, Proceedings of the National Academy of Sciences.

[23]  David W. Nauen,et al.  Synaptic dysregulation in a human iPS cell model of mental disorders , 2014, Nature.

[24]  Keizo Takao,et al.  Genomic responses in mouse models greatly mimic human inflammatory diseases , 2014, Proceedings of the National Academy of Sciences.

[25]  T. Miyakawa,et al.  Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia , 2014, Molecular Brain.

[26]  M. Owen,et al.  Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. , 2014, Schizophrenia bulletin.

[27]  P. Jagodziński,et al.  Mutations of TP53 Gene and Oxidative Stress in Alzheimer’s Disease Patients , 2014 .

[28]  Christian Stolte,et al.  COMPARTMENTS: unification and visualization of protein subcellular localization evidence , 2014, Database J. Biol. Databases Curation.

[29]  John R. Yates,et al.  Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.

[30]  T. Miyakawa,et al.  Chronic fluoxetine treatment reduces parvalbumin expression and perineuronal netsin gamma-aminobutyric acidergic interneurons of the frontal cortex in adultmice , 2013, Molecular Brain.

[31]  T. Miyakawa,et al.  Chronic fluoxetine treatment reduces parvalbumin expression and perineuronal nets in gamma-aminobutyric acidergic interneurons of the frontal cortex in adult mice , 2013, Molecular Brain.

[32]  Neil D. Lawrence,et al.  Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. , 2013, Brain : a journal of neurology.

[33]  D. Lewis,et al.  Dendritic spine pathology in schizophrenia , 2013, Neuroscience.

[34]  J. Schreiber,et al.  Genome-Wide Profiling of the Activity-Dependent Hippocampal Transcriptome , 2013, PloS one.

[35]  L. Martin,et al.  Aberrant Regulation of DNA Methylation in Amyotrophic Lateral Sclerosis: A New Target of Disease Mechanisms , 2013, Neurotherapeutics.

[36]  T. Miyakawa,et al.  Immature Dentate Gyrus: An Endophenotype of Neuropsychiatric Disorders , 2013, Neural plasticity.

[37]  J. Kogan,et al.  The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease , 2013, Bipolar disorders.

[38]  Hironori K. Nakamura,et al.  Synaptosomal-associated protein 25 mutation induces immaturity of the dentate granule cells of adult mice , 2013, Molecular Brain.

[39]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[40]  Hironori K. Nakamura,et al.  Deficiency of Schnurri-2, an MHC Enhancer Binding Protein, Induces Mild Chronic Inflammation in the Brain and Confers Molecular, Neuronal, and Behavioral Phenotypes Related to Schizophrenia , 2013, Neuropsychopharmacology.

[41]  Bin Xu,et al.  Derepression of a Neuronal Inhibitor due to miRNA Dysregulation in a Schizophrenia-Related Microdeletion , 2013, Cell.

[42]  J. Kállai,et al.  Correlation between calbindin expression in granule cells of the resected hippocampal dentate gyrus and verbal memory in temporal lobe epilepsy , 2012, Epilepsy & Behavior.

[43]  M. Gandal,et al.  Measuring the Maturity of the Fast-Spiking Interneuron Transcriptional Program in Autism, Schizophrenia, and Bipolar Disorder , 2012, PloS one.

[44]  E. Hoffman,et al.  Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis , 2012, Brain and behavior.

[45]  S. Berretta.  Extracellular matrix abnormalities in schizophrenia , 2012, Neuropharmacology.

[46]  A. Zhavoronkov,et al.  Gadd45 proteins: Relevance to aging, longevity and age-related pathologies , 2012, Ageing Research Reviews.

[47]  E. Holmes,et al.  Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients , 2011, Molecular Psychiatry.

[48]  L. Martin,et al.  Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.

[49]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[50]  S. L. Stevens,et al.  LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury , 2011, Journal of Neuroinflammation.

[51]  F. Sung,et al.  Bidirectional relation between schizophrenia and epilepsy: A population‐based retrospective cohort study , 2011, Epilepsia.

[52]  Tao Yang,et al.  Multiple Preconditioning Paradigms Converge on Interferon Regulatory Factor-Dependent Signaling to Promote Tolerance to Ischemic Brain Injury , 2011, The Journal of Neuroscience.

[53]  Fred H. Gage,et al.  Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.

[54]  M. Webster,et al.  Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. , 2010, The American journal of psychiatry.

[55]  Jim van Os,et al.  The environment and schizophrenia , 2010, Nature.

[56]  M. Ronaghi,et al.  Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data , 2010, PloS one.

[57]  T. Miyakawa,et al.  Reversal of hippocampal neuronal maturation by serotonergic antidepressants , 2010, Proceedings of the National Academy of Sciences.

[58]  T. Woo,et al.  Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. , 2010, Archives of general psychiatry.

[59]  Tsuyoshi Miyakawa,et al.  Dissection of Hippocampal Dentate Gyrus from Adult Mouse , 2009, Journal of visualized experiments : JoVE.

[60]  E. Ginns,et al.  Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia , 2009, Biological Psychiatry.

[61]  A. Sawa,et al.  Schizophrenia and epilepsy: Is there a shared susceptibility? , 2009, Neuroscience Research.

[62]  K. Fukunaga,et al.  Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders , 2008, European Psychiatry.

[63]  D. Javitt,et al.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia , 2008, Trends in Neurosciences.

[64]  Colin Kehrer,et al.  Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia , 2008, Frontiers in molecular neuroscience.

[65]  H. M. Morris,et al.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.

[66]  Yukihiro Noda,et al.  Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment , 2007, Neurochemistry International.

[67]  J. Coyle,et al.  Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis , 2006, Cellular and Molecular Neurobiology.

[68]  Paul J. Harrison.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications , 2004, Psychopharmacology.

[69]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[70]  J. Julien,et al.  Cell Cycle Regulators in the Neuronal Death Pathway of Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 1 , 2003, The Journal of Neuroscience.

[71]  Gavin P. Reynolds,et al.  A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia , 2002, Schizophrenia Research.

[72]  T. Freund,et al.  Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy , 1997, Neuroscience.

[73]  S. Tonegawa,et al.  Limbic epilepsy in transgenic mice carrying a Ca2+/calmodulin-dependent kinase II alpha-subunit mutation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Reynolds,et al.  Beyond the Dopamine Hypothesis , 1989, British Journal of Psychiatry.

[75]  Majnu John,et al.  Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder. , 2014, Schizophrenia bulletin.

[76]  David George,et al.  Microarray analysis of postictal transcriptional regulation of neuropeptides , 2007, Journal of Molecular Neuroscience.

[77]  Olga V. Demler,et al.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. , 2000, Bulletin of the World Health Organization.

[78]  T M Hyde,et al.  Seizures and schizophrenia. , 1997, Schizophrenia bulletin.